The application for the next-generation mitomycin formulation is supported by 3-month complete response data from the phase 3 UTOPIA trial.
Is Hormone Therapy Right for Menopause Symptoms? OB-GYNs Are Offering These More Detailed Guidelines
New ACOG guidance says benefits outweigh risks for most women, with nonhormonal options for those who can’t take hormones ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results